Audentes Therapeutics, Inc. - FORM S-1 - EX-21.1 - SUBSIDIARY OF REGISTRANT - January 4, 2016

Attached files

file	filename
S-1 - S-1 - Audentes Therapeutics, Inc.	d892618ds1.htm
EX-4.2 - INVESTORS' RIGHTS AGREEMENT - Audentes Therapeutics, Inc.	d892618dex42.htm
EX-3.1 - RESTATED CERTIFICATE OF INCORPORATION - Audentes Therapeutics, Inc.	d892618dex31.htm
EX-3.3 - AMENDED AND RESTATED BYLAWS - Audentes Therapeutics, Inc.	d892618dex33.htm
EX-10.2 - 2012 EQUITY INCENTIVE PLAN - Audentes Therapeutics, Inc.	d892618dex102.htm
EX-10.9 - OFFICE LEASE (MONTGOMERY STREET) - Audentes Therapeutics, Inc.	d892618dex109.htm
EX-10.10 - SUBLEASE (SOLSTICE NEUROSCIENCES) - Audentes Therapeutics, Inc.	d892618dex1010.htm
EX-23.1 - CONSENT OF KPMG LLP - Audentes Therapeutics, Inc.	d892618dex231.htm
EX-10.12 - COLLABORATIVE DEVELOPMENT AGREEMENT (GENETHON) - Audentes Therapeutics, Inc.	d892618dex1012.htm
EX-10.17 - LICENSE AGREEMENT (REGENXBIO - CN) - Audentes Therapeutics, Inc.	d892618dex1017.htm
EX-10.13 - LICENSE AGREEMENT (FONDAZIONE SALVATORE MAUGERI) - Audentes Therapeutics, Inc.	d892618dex1013.htm
EX-10.16 - LICENSE AGREEMENT (REGENXBIO - CPVT) - Audentes Therapeutics, Inc.	d892618dex1016.htm
EX-10.14 - EXCLUSIVE LICENSE AGREEMENT (UNIVERSITY OF FLORIDA) - Audentes Therapeutics, Inc.	d892618dex1014.htm
EX-10.15 - LICENSE AGREEMENT (REGENX BIOSCIENCES) - Audentes Therapeutics, Inc.	d892618dex1015.htm
EX-10.11 - OFFICE LEASE (CALIFORNIA STREET) - Audentes Therapeutics, Inc.	d892618dex1011.htm

Exhibit 21.1

Subsidiary of Audentes Therapeutics, Inc.


Name of Subsidiary		Jurisdiction of Incorporation or Organization

None